Menju Toshi

メンジュトシ | Menju Toshi

Research field (1)： Respiratory surgery

Research theme for competitive and other funds (12)：

2020 - 2024 The elucidation of mechanisms and the development of novel therapeutic methods for mutant p53-induced EMT in lung cancer
2018 - 2020 The elucidation of key signaling pathways and the establishment of treatment strategies for mutant p53-induced epithelio-mesenchymal transition in lung cancer
2017 - 2020 The elucidation of the novel therapy specific for lung cancer targeting Arf6-induced EMT
2017 - 2019 The elucidation of the clinical significance and the mechanisms of acquired drug resistance with activated FA pathway in cancer cells
2016 - 2018 Comprehensive analyses of transcriptome and DNA copy number variations in thymic cancer

Show all

Papers (91)：

Tatsuya Ogimoto, Hiroaki Ozasa, Takahiro Tsuji, Tomoko Funazo, Masatoshi Yamazoe, Kentaro Hashimoto, Hiroshi Yoshida, Kazutaka Hosoya, Hitomi Ajimizu, Takashi Nomizo, et al. Combination therapy with EGFR tyrosine kinase inhibitors and TEAD inhibitor increases tumor suppression effects in EGFR mutation-positive lung cancer. Molecular Cancer Therapeutics. 2023
Kazuhiro Terada, Akihiko Yoshizawa, Xiaoqing Liu, Hiroaki Ito, Masatsugu Hamaji, Toshi Menju, Hiroshi Date, Ryoma Bise, Hironori Haga. Deep Learning for Predicting Effect of Neoadjuvant Therapies in Non-small Cell Lung Carcinomas With Histologic Images. Modern Pathology. 2023. 36. 11. 100302-100302
Koichi Hasegawa, Ryo Miyata, Toshi Menju, Toyohiro Hirai, Hiroshi Date, Atsuyasu Sato. Protocol for cell-type-specific tissue reconstruction in the murine lung fibrogenic microenvironment. STAR protocols. 2023. 4. 1. 102018-102018
Itsuki Yuasa, Masatsugu Hamaji, Hiroaki Ozasa, Yuichi Sakamori, Hironori Yoshida, Yojiro Yutaka, Toshi Menju, Toyohiro Hirai, Hiroshi Date. Outcomes of immune checkpoint inhibitors for postoperative recurrence of non-small cell lung cancer. General Thoracic and Cardiovascular Surgery. 2023
Yojiro Yutaka, Kazuhiko Terada, Satona Tanaka, Yoshito Yamada, Akihiro Ohsumi, Daisuke Nakajima, Masatsugu Hamaji, Toshi Menju, Akihiko Yoshizawa, Hiroshi Date. Prognostic impact of pathologically confirmed rib invasion in patients with lung cancer requiring chest wall resection. Journal of thoracic disease. 2022. 14. 12. 4660-4668

ｍore...

MISC (78)：

毛受暁史, 甲貴文, 有賀希, 小林萌, 松本瞭, 河野幹寛, 高橋守, 西川滋人, 田中里奈, 豊洋二郎, et al. 進行期扁平上皮肺癌に対する治療方針:術前導入化学放射線療法. 日本胸部外科学会定期学術集会(Web). 2023. 76th
高橋守, 坂之上一朗, 河野幹寛, 田中里奈, 西川滋人, 豊洋次郎, 大角明宏, 濱路政嗣, 中島大輔, 毛受暁史, et al. 肺移植術における術前PNIと術後短期成績の相関. 日本移植学会総会プログラム抄録集. 2023. 59th (Web)
岩本拓也, 豊洋次郎, 松本和久, 湯浅樹, 伊達直希, 栢分秀直, 田中里奈, 山田義人, 大角明宏, 中島大輔, et al. 病理診断にてlepidic type SqCCと診断された1例. 肺癌. 2021. 61. 5. 452-452
森村祐樹, 濱路政嗣, 栢分秀直, 山田義人, 田中里奈, 豊洋次郎, 大角明宏, 中島大輔, 毛受暁史, 伊達洋至. 胸部腫瘍に対する経胸骨柄アプローチ(Transmanubrial approach)の周術期成績. 肺癌. 2021. 61. 5. 454-454
藤本遼, 中島大輔, 栢分秀直, 田中里奈, 山田義人, 豊洋次郎, 大角明宏, 濱路政嗣, 毛受暁史, 伊達洋至. 肺移植後におけるドナー由来の抗human leucocyte antigen(HLA)抗体の出現. 移植. 2021. 56. 総会臨時. P1-28

ｍore...

※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page